CLINICAL_TRIALS
trial_result
· 2015-09-03
Clinical Trial Update: A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. [Phase 4]
Summary
Phase 4 trial evaluating Xeloda (capecitabine) as adjuvant monotherapy in colon cancer; the study is completed and results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 4 | Status: COMPLETED | Results posted: 2015-09-03